Childhood asthma diagnosis and use of asthma medication

M Cagney1, C R MacIntyre, P B McIntyre

  • 1Westmead Hospital, New South Wales.

Insights

This study found a high prevalence of childhood asthma in Western Sydney, with 31% of children diagnosed. Early diagnosis before age two may contribute to overdiagnosis, impacting accurate asthma burden assessment.

Area of Science:

  • Pediatric respiratory health
  • Epidemiology of childhood asthma

Background:

  • Asthma is a significant public health concern in children.
  • Understanding the prevalence and associated factors of childhood asthma is crucial for effective management and prevention strategies.

Purpose of the Study:

  • To determine the prevalence and burden of asthma in children aged 5-14 years in Western Sydney.
  • To identify factors associated with a reported asthma diagnosis in this population.

Main Methods:

  • A cross-sectional, randomized, computer-assisted telephone survey was conducted.
  • A community-based sample of 2020 children aged 5-14 years was surveyed over 20 days in June-July 2000.

Main Results:

  • 31% of children had a reported asthma diagnosis, with 42% diagnosed at age two or younger.
  • 21% of children used asthma medications in the previous year.
  • Factors associated with asthma diagnosis included male gender, birth in Australia, English-speaking household, Aboriginality, health care card possession, prior pneumonia, pertussis, and croup.

Conclusions:

  • A high prevalence of asthma and medication use was confirmed in the studied pediatric population.
  • The high rate of diagnosis before age two suggests potential overdiagnosis, which may inflate the apparent asthma prevalence.
  • Further research is needed to refine diagnostic criteria and improve the accuracy of asthma burden estimation in young children.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: